Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of cell killing (GO:0031342) | 6.19557852 |
2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.19557852 |
3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.46136107 |
4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.31551603 |
5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.24920745 |
6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.04333717 |
7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.04333717 |
8 | modulation by symbiont of host immune response (GO:0052553) | 5.04333717 |
9 | positive regulation by symbiont of host defense response (GO:0052509) | 5.04333717 |
10 | modulation by symbiont of host defense response (GO:0052031) | 5.04333717 |
11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.04333717 |
12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.93480313 |
13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.82408610 |
14 | neutrophil activation involved in immune response (GO:0002283) | 4.46669372 |
15 | response to peptidoglycan (GO:0032494) | 4.34410510 |
16 | detection of other organism (GO:0098543) | 4.33011482 |
17 | macrophage activation involved in immune response (GO:0002281) | 4.27925540 |
18 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.19950909 |
19 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.18349689 |
20 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.16975062 |
21 | detection of bacterium (GO:0016045) | 4.12106263 |
22 | leukocyte aggregation (GO:0070486) | 4.07369138 |
23 | negative regulation of interleukin-12 production (GO:0032695) | 4.03997964 |
24 | detection of molecule of bacterial origin (GO:0032490) | 4.01787381 |
25 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.88268628 |
26 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.87800775 |
27 | regulation of gamma-delta T cell activation (GO:0046643) | 3.86706765 |
28 | detection of external biotic stimulus (GO:0098581) | 3.85745678 |
29 | type I interferon signaling pathway (GO:0060337) | 3.72735130 |
30 | cellular response to type I interferon (GO:0071357) | 3.72735130 |
31 | response to type I interferon (GO:0034340) | 3.70133135 |
32 | neutrophil activation (GO:0042119) | 3.69453181 |
33 | response to interleukin-15 (GO:0070672) | 3.65790338 |
34 | cellular extravasation (GO:0045123) | 3.62900370 |
35 | response to muramyl dipeptide (GO:0032495) | 3.62731274 |
36 | regulation of T cell tolerance induction (GO:0002664) | 3.60955665 |
37 | granulocyte activation (GO:0036230) | 3.55997324 |
38 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.49182896 |
39 | negative regulation of T cell mediated immunity (GO:0002710) | 3.41963338 |
40 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.40458614 |
41 | negative thymic T cell selection (GO:0045060) | 3.39400154 |
42 | detection of biotic stimulus (GO:0009595) | 3.38750160 |
43 | negative T cell selection (GO:0043383) | 3.37225072 |
44 | response to host immune response (GO:0052572) | 3.36621835 |
45 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.36621835 |
46 | regulation of tolerance induction (GO:0002643) | 3.34445481 |
47 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.29296044 |
48 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.25945892 |
49 | cellular response to interleukin-15 (GO:0071350) | 3.22960296 |
50 | immunoglobulin mediated immune response (GO:0016064) | 3.22953999 |
51 | respiratory burst (GO:0045730) | 3.22877381 |
52 | microglial cell activation (GO:0001774) | 3.22305763 |
53 | germinal center formation (GO:0002467) | 3.21187076 |
54 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.20027193 |
55 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.18716283 |
56 | response to host (GO:0075136) | 3.18716283 |
57 | response to host defenses (GO:0052200) | 3.18716283 |
58 | macrophage activation (GO:0042116) | 3.18423328 |
59 | neutrophil mediated immunity (GO:0002446) | 3.17215390 |
60 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.17035714 |
61 | myeloid cell activation involved in immune response (GO:0002275) | 3.15352251 |
62 | positive regulation of tolerance induction (GO:0002645) | 3.10064243 |
63 | regulation of mast cell degranulation (GO:0043304) | 3.08902309 |
64 | tolerance induction (GO:0002507) | 3.07552433 |
65 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.00615800 |
66 | defense response to protozoan (GO:0042832) | 2.99729969 |
67 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.99580480 |
68 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.98129657 |
69 | B cell receptor signaling pathway (GO:0050853) | 2.96244690 |
70 | NIK/NF-kappaB signaling (GO:0038061) | 2.95465666 |
71 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.94469196 |
72 | T cell migration (GO:0072678) | 2.93840299 |
73 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.92607732 |
74 | activated T cell proliferation (GO:0050798) | 2.90938235 |
75 | positive thymic T cell selection (GO:0045059) | 2.90188573 |
76 | myeloid leukocyte mediated immunity (GO:0002444) | 2.89912979 |
77 | regulation of necroptotic process (GO:0060544) | 2.87985688 |
78 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.87659691 |
79 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.87513134 |
80 | positive regulation of interferon-alpha production (GO:0032727) | 2.86457879 |
81 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.84435917 |
82 | regulation of B cell differentiation (GO:0045577) | 2.84230915 |
83 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.84015710 |
84 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.84015710 |
85 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.83422850 |
86 | negative regulation of type 2 immune response (GO:0002829) | 2.83387125 |
87 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.83183739 |
88 | negative regulation of innate immune response (GO:0045824) | 2.77326356 |
89 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.76882248 |
90 | regulation of interferon-alpha production (GO:0032647) | 2.76564380 |
91 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.74309624 |
92 | T cell selection (GO:0045058) | 2.71631837 |
93 | positive T cell selection (GO:0043368) | 2.71581396 |
94 | I-kappaB phosphorylation (GO:0007252) | 2.69993557 |
95 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.69965191 |
96 | response to protozoan (GO:0001562) | 2.68364987 |
97 | response to interferon-alpha (GO:0035455) | 2.68249188 |
98 | regulation of regulatory T cell differentiation (GO:0045589) | 2.66857680 |
99 | interferon-gamma secretion (GO:0072643) | 2.66387384 |
100 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.65191365 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.34878056 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.52367775 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.08318758 |
4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.01784089 |
5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.59568584 |
6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.55469230 |
7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.28831817 |
8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.13626106 |
9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.92795109 |
10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.91617766 |
11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.82583781 |
12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.82380874 |
13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.73175085 |
14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.71829852 |
15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.70027335 |
16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.64234714 |
17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.42067226 |
18 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.37030249 |
19 | MAF_26560356_Chip-Seq_TH1_Human | 2.27853670 |
20 | SPI1_23127762_ChIP-Seq_K562_Human | 2.27300639 |
21 | MYB_26560356_Chip-Seq_TH2_Human | 2.27232592 |
22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.25525404 |
23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.23606684 |
24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22904429 |
25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.21769657 |
26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.19114884 |
27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.16680895 |
28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.15483020 |
29 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.11733364 |
30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.04131594 |
31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.02565277 |
32 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.98589512 |
33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.97463944 |
34 | UTX_26944678_Chip-Seq_JUKART_Human | 1.97037301 |
35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.96327567 |
36 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.96181886 |
37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.92832523 |
38 | MYB_26560356_Chip-Seq_TH1_Human | 1.92489973 |
39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.87570123 |
40 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.77342010 |
41 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.76521335 |
42 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.74148607 |
43 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73753239 |
44 | MAF_26560356_Chip-Seq_TH2_Human | 1.72692766 |
45 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.71868859 |
46 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.68278171 |
47 | MYC_22102868_ChIP-Seq_BL_Human | 1.67797149 |
48 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.66421483 |
49 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.60695954 |
50 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.58408542 |
51 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.55765734 |
52 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.54948688 |
53 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.53130381 |
54 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.50638767 |
55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46254586 |
56 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.39482738 |
57 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.38751633 |
58 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.37520662 |
59 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.35773560 |
60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34804090 |
61 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.29676371 |
62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26890223 |
63 | GATA3_26560356_Chip-Seq_TH2_Human | 1.23117924 |
64 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23019794 |
65 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20721232 |
66 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16654483 |
67 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16605070 |
68 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16391183 |
69 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15139872 |
70 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12542599 |
71 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12224314 |
72 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11356385 |
73 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.11114193 |
74 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10761738 |
75 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.08221763 |
76 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.07734806 |
77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02688467 |
78 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99529187 |
79 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.99277543 |
80 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.97463627 |
81 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94771370 |
82 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94001748 |
83 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93160608 |
84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92605270 |
85 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91628864 |
86 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.86745684 |
87 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.86382158 |
88 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.85831432 |
89 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85719403 |
90 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.82125951 |
91 | KDM2B_26808549_Chip-Seq_K562_Human | 0.81800299 |
92 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79378109 |
93 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.77342470 |
94 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.77085126 |
95 | GATA2_19941826_ChIP-Seq_K562_Human | 0.76945167 |
96 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.76727480 |
97 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.75978332 |
98 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.74592509 |
99 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.74423082 |
100 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.72580056 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003724_increased_susceptibility_to | 4.89244950 |
2 | MP0003436_decreased_susceptibility_to | 4.48317152 |
3 | MP0003303_peritoneal_inflammation | 3.74320592 |
4 | MP0001835_abnormal_antigen_presentation | 3.46854092 |
5 | MP0002419_abnormal_innate_immunity | 2.86452492 |
6 | MP0009785_altered_susceptibility_to | 2.84839030 |
7 | MP0006082_CNS_inflammation | 2.80548722 |
8 | MP0001800_abnormal_humoral_immune | 2.79744106 |
9 | MP0001790_abnormal_immune_system | 2.79083546 |
10 | MP0005387_immune_system_phenotype | 2.79083546 |
11 | MP0005000_abnormal_immune_tolerance | 2.77740618 |
12 | MP0005671_abnormal_response_to | 2.77186727 |
13 | MP0005025_abnormal_response_to | 2.63985754 |
14 | MP0002723_abnormal_immune_serum | 2.50417185 |
15 | MP0000685_abnormal_immune_system | 2.49278490 |
16 | MP0002452_abnormal_antigen_presenting | 2.42041857 |
17 | MP0003300_gastrointestinal_ulcer | 2.36012296 |
18 | MP0002420_abnormal_adaptive_immunity | 2.32978594 |
19 | MP0001819_abnormal_immune_cell | 2.31535449 |
20 | MP0001533_abnormal_skeleton_physiology | 2.30903813 |
21 | MP0002148_abnormal_hypersensitivity_rea | 2.28479903 |
22 | MP0003172_abnormal_lysosome_physiology | 2.22664461 |
23 | MP0003191_abnormal_cellular_cholesterol | 2.19975155 |
24 | MP0003763_abnormal_thymus_physiology | 2.17036119 |
25 | MP0003828_pulmonary_edema | 2.09295659 |
26 | MP0002405_respiratory_system_inflammati | 2.08171637 |
27 | MP0008260_abnormal_autophagy | 1.97289657 |
28 | MP0004947_skin_inflammation | 1.90570789 |
29 | MP0005451_abnormal_body_composition | 1.85515477 |
30 | MP0002398_abnormal_bone_marrow | 1.77114899 |
31 | MP0004510_myositis | 1.76904492 |
32 | MP0000716_abnormal_immune_system | 1.75676951 |
33 | MP0010155_abnormal_intestine_physiology | 1.71128763 |
34 | MP0009764_decreased_sensitivity_to | 1.70550688 |
35 | MP0001845_abnormal_inflammatory_respons | 1.68437639 |
36 | MP0005464_abnormal_platelet_physiology | 1.67227004 |
37 | MP0009333_abnormal_splenocyte_physiolog | 1.55835561 |
38 | MP0000858_altered_metastatic_potential | 1.52291516 |
39 | MP0000689_abnormal_spleen_morphology | 1.47651802 |
40 | MP0001545_abnormal_hematopoietic_system | 1.45928398 |
41 | MP0005397_hematopoietic_system_phenotyp | 1.45928398 |
42 | MP0002722_abnormal_immune_system | 1.44297548 |
43 | MP0002998_abnormal_bone_remodeling | 1.42807831 |
44 | MP0004883_abnormal_blood_vessel | 1.42731732 |
45 | MP0008469_abnormal_protein_level | 1.40173143 |
46 | MP0009278_abnormal_bone_marrow | 1.38696477 |
47 | MP0002132_abnormal_respiratory_system | 1.37744080 |
48 | MP0003866_abnormal_defecation | 1.36486981 |
49 | MP0002429_abnormal_blood_cell | 1.35346701 |
50 | MP0005164_abnormal_response_to | 1.33342869 |
51 | MP0005058_abnormal_lysosome_morphology | 1.32517882 |
52 | MP0001851_eye_inflammation | 1.30970462 |
53 | MP0000703_abnormal_thymus_morphology | 1.29972029 |
54 | MP0002396_abnormal_hematopoietic_system | 1.29945418 |
55 | MP0001853_heart_inflammation | 1.27961048 |
56 | MP0003279_aneurysm | 1.26896215 |
57 | MP0000465_gastrointestinal_hemorrhage | 1.25889522 |
58 | MP0005310_abnormal_salivary_gland | 1.21794612 |
59 | MP0003656_abnormal_erythrocyte_physiolo | 1.19925398 |
60 | MP0003448_altered_tumor_morphology | 1.19067780 |
61 | MP0000604_amyloidosis | 1.17854886 |
62 | MP0002933_joint_inflammation | 1.17317343 |
63 | MP0002166_altered_tumor_susceptibility | 1.12509679 |
64 | MP0000015_abnormal_ear_pigmentation | 1.12145627 |
65 | MP0003091_abnormal_cell_migration | 1.11396610 |
66 | MP0003075_altered_response_to | 1.10584545 |
67 | MP0003183_abnormal_peptide_metabolism | 1.05313525 |
68 | MP0005390_skeleton_phenotype | 1.04769927 |
69 | MP0006054_spinal_hemorrhage | 1.00153389 |
70 | MP0008004_abnormal_stomach_pH | 0.99426141 |
71 | MP0000343_altered_response_to | 0.98769597 |
72 | MP0004808_abnormal_hematopoietic_stem | 0.98310283 |
73 | MP0002332_abnormal_exercise_endurance | 0.98277629 |
74 | MP0003690_abnormal_glial_cell | 0.96761082 |
75 | MP0005166_decreased_susceptibility_to | 0.95665882 |
76 | MP0010368_abnormal_lymphatic_system | 0.94362752 |
77 | MP0003221_abnormal_cardiomyocyte_apopto | 0.92072411 |
78 | MP0004381_abnormal_hair_follicle | 0.90044695 |
79 | MP0002277_abnormal_respiratory_mucosa | 0.89855702 |
80 | MP0003329_amyloid_beta_deposits | 0.88777595 |
81 | MP0008438_abnormal_cutaneous_collagen | 0.88349980 |
82 | MP0001958_emphysema | 0.87740939 |
83 | MP0000767_abnormal_smooth_muscle | 0.86521032 |
84 | MP0003795_abnormal_bone_structure | 0.82818226 |
85 | MP0003566_abnormal_cell_adhesion | 0.81255731 |
86 | MP0002006_tumorigenesis | 0.78704740 |
87 | MP0009763_increased_sensitivity_to | 0.78646903 |
88 | MP0000249_abnormal_blood_vessel | 0.78323540 |
89 | MP0003045_fibrosis | 0.74422253 |
90 | MP0001542_abnormal_bone_strength | 0.71995242 |
91 | MP0005409_darkened_coat_color | 0.71014870 |
92 | MP0001663_abnormal_digestive_system | 0.69318008 |
93 | MP0003705_abnormal_hypodermis_morpholog | 0.68821026 |
94 | MP0002009_preneoplasia | 0.67817730 |
95 | MP0009765_abnormal_xenobiotic_induced | 0.61156309 |
96 | MP0005388_respiratory_system_phenotype | 0.60768806 |
97 | MP0002133_abnormal_respiratory_system | 0.60768806 |
98 | MP0009840_abnormal_foam_cell | 0.60666562 |
99 | MP0008874_decreased_physiological_sensi | 0.57407034 |
100 | MP0002928_abnormal_bile_duct | 0.55786455 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 5.79623458 |
2 | Myositis (HP:0100614) | 5.30775818 |
3 | Orchitis (HP:0100796) | 5.08993889 |
4 | Recurrent bacterial skin infections (HP:0005406) | 4.94815454 |
5 | Recurrent abscess formation (HP:0002722) | 4.83781192 |
6 | Abnormality of macrophages (HP:0004311) | 4.80134699 |
7 | Optic neuritis (HP:0100653) | 4.77945222 |
8 | Retrobulbar optic neuritis (HP:0100654) | 4.77945222 |
9 | Gastrointestinal infarctions (HP:0005244) | 4.56522839 |
10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.32641828 |
11 | Stomatitis (HP:0010280) | 4.25336833 |
12 | Peritonitis (HP:0002586) | 4.10983014 |
13 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.97563989 |
14 | Mediastinal lymphadenopathy (HP:0100721) | 3.87633852 |
15 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.86616144 |
16 | Recurrent fungal infections (HP:0002841) | 3.73255934 |
17 | Vasculitis (HP:0002633) | 3.43737083 |
18 | Recurrent skin infections (HP:0001581) | 3.43538861 |
19 | Recurrent cutaneous fungal infections (HP:0011370) | 3.37119543 |
20 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.37119543 |
21 | Keratoconjunctivitis sicca (HP:0001097) | 3.29303064 |
22 | Meningitis (HP:0001287) | 3.29033283 |
23 | Obstructive lung disease (HP:0006536) | 3.27612024 |
24 | Chronic obstructive pulmonary disease (HP:0006510) | 3.27612024 |
25 | Encephalitis (HP:0002383) | 3.24899387 |
26 | Spontaneous hematomas (HP:0007420) | 3.19641130 |
27 | Abnormality of T cell number (HP:0011839) | 3.09560639 |
28 | Increased IgM level (HP:0003496) | 3.09531729 |
29 | T lymphocytopenia (HP:0005403) | 3.07445317 |
30 | Chest pain (HP:0100749) | 3.07202129 |
31 | Gingivitis (HP:0000230) | 3.01828960 |
32 | Keratoconjunctivitis (HP:0001096) | 2.97141229 |
33 | Pulmonary infiltrates (HP:0002113) | 2.96852396 |
34 | Episodic fever (HP:0001954) | 2.88335063 |
35 | Abnormality of the peritoneum (HP:0002585) | 2.87688094 |
36 | Leukocytosis (HP:0001974) | 2.84561180 |
37 | Increased IgE level (HP:0003212) | 2.82942498 |
38 | Hemoptysis (HP:0002105) | 2.82689190 |
39 | Urticaria (HP:0001025) | 2.79347891 |
40 | Gingival bleeding (HP:0000225) | 2.72801212 |
41 | Arterial thrombosis (HP:0004420) | 2.72778801 |
42 | Cellulitis (HP:0100658) | 2.72174246 |
43 | Recurrent viral infections (HP:0004429) | 2.56465729 |
44 | Amyloidosis (HP:0011034) | 2.47398576 |
45 | Abnormality of T cells (HP:0002843) | 2.47286068 |
46 | Pulmonary embolism (HP:0002204) | 2.46988470 |
47 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.44978088 |
48 | Prolonged bleeding time (HP:0003010) | 2.43951392 |
49 | Epistaxis (HP:0000421) | 2.39421498 |
50 | Granulocytopenia (HP:0001913) | 2.37386446 |
51 | Hypochromic anemia (HP:0001931) | 2.37214431 |
52 | Hypergammaglobulinemia (HP:0010702) | 2.34871983 |
53 | Hypochromic microcytic anemia (HP:0004840) | 2.34784741 |
54 | Inflammation of the large intestine (HP:0002037) | 2.34627806 |
55 | Pustule (HP:0200039) | 2.29848271 |
56 | Gastrointestinal inflammation (HP:0004386) | 2.29563290 |
57 | Anorexia (HP:0002039) | 2.27497066 |
58 | Abnormality of glycolipid metabolism (HP:0010969) | 2.23531911 |
59 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.23531911 |
60 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.23531911 |
61 | Acute hepatic failure (HP:0006554) | 2.22639944 |
62 | Abnormality of the pleura (HP:0002103) | 2.21482409 |
63 | Panhypogammaglobulinemia (HP:0003139) | 2.21274823 |
64 | Glomerulopathy (HP:0100820) | 2.20248473 |
65 | Lymphopenia (HP:0001888) | 2.16599409 |
66 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.13162682 |
67 | Autoimmune thrombocytopenia (HP:0001973) | 2.12981111 |
68 | Eosinophilia (HP:0001880) | 2.11942219 |
69 | Keratitis (HP:0000491) | 2.11263619 |
70 | Loss of speech (HP:0002371) | 2.10970739 |
71 | Colitis (HP:0002583) | 2.10177924 |
72 | Gangrene (HP:0100758) | 2.09581829 |
73 | Abnormality of T cell physiology (HP:0011840) | 2.06962491 |
74 | Abnormality of the endocardium (HP:0004306) | 2.03648123 |
75 | Recurrent bronchitis (HP:0002837) | 2.02088355 |
76 | Dysostosis multiplex (HP:0000943) | 2.01372337 |
77 | Dilatation of the ascending aorta (HP:0005111) | 1.99264732 |
78 | Sepsis (HP:0100806) | 1.97806904 |
79 | Osteomyelitis (HP:0002754) | 1.97159832 |
80 | Abnormality of the pericardium (HP:0001697) | 1.96392040 |
81 | Interstitial pulmonary disease (HP:0006530) | 1.93927206 |
82 | Myocardial infarction (HP:0001658) | 1.92120319 |
83 | Agammaglobulinemia (HP:0004432) | 1.89849119 |
84 | Viral hepatitis (HP:0006562) | 1.89644412 |
85 | Abnormality of eosinophils (HP:0001879) | 1.88309861 |
86 | Hematochezia (HP:0002573) | 1.85581178 |
87 | Skin ulcer (HP:0200042) | 1.84717982 |
88 | Vertigo (HP:0002321) | 1.84673207 |
89 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.82658341 |
90 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.82658341 |
91 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.82658341 |
92 | Joint swelling (HP:0001386) | 1.82000631 |
93 | Gastrointestinal stroma tumor (HP:0100723) | 1.79851394 |
94 | Autoimmune hemolytic anemia (HP:0001890) | 1.79715364 |
95 | Hepatosplenomegaly (HP:0001433) | 1.79147221 |
96 | Amaurosis fugax (HP:0100576) | 1.79091509 |
97 | Subacute progressive viral hepatitis (HP:0006572) | 1.78831929 |
98 | Systemic lupus erythematosus (HP:0002725) | 1.78776509 |
99 | Papilledema (HP:0001085) | 1.78702702 |
100 | Choroideremia (HP:0001139) | 1.76523076 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 3.67111765 |
2 | MAP4K1 | 3.32603092 |
3 | TYK2 | 2.93564672 |
4 | PRPF4B | 2.74779830 |
5 | BLK | 2.71310429 |
6 | ERN1 | 2.60064938 |
7 | IRAK4 | 2.52231851 |
8 | CSK | 2.41884210 |
9 | MAP3K14 | 2.41064187 |
10 | MAP2K3 | 2.34838691 |
11 | MAP3K13 | 2.25839070 |
12 | JAK3 | 2.13627982 |
13 | TXK | 2.09743982 |
14 | SIK3 | 2.03254531 |
15 | ZAP70 | 1.97537254 |
16 | IKBKE | 1.93327809 |
17 | EPHB1 | 1.86950022 |
18 | FES | 1.84573475 |
19 | GRK6 | 1.80940491 |
20 | MAP3K3 | 1.76833932 |
21 | TBK1 | 1.76055802 |
22 | TNK2 | 1.73417514 |
23 | JAK1 | 1.69343656 |
24 | FGR | 1.58180052 |
25 | SIK2 | 1.52980516 |
26 | HCK | 1.48730162 |
27 | TAOK1 | 1.37449969 |
28 | BTK | 1.36310754 |
29 | JAK2 | 1.32290626 |
30 | SYK | 1.31682281 |
31 | MAP3K11 | 1.31333487 |
32 | RIPK1 | 1.29135829 |
33 | PRKD2 | 1.26870149 |
34 | TGFBR2 | 1.17302742 |
35 | LCK | 1.17027937 |
36 | KSR2 | 1.15348270 |
37 | TAOK3 | 1.11532264 |
38 | LYN | 1.11408405 |
39 | TEC | 1.10092031 |
40 | MAP3K1 | 1.09666411 |
41 | KIT | 1.09138432 |
42 | FGFR4 | 1.08566287 |
43 | IKBKB | 1.08331813 |
44 | GRK7 | 1.07231433 |
45 | MATK | 1.06093220 |
46 | CSF1R | 1.05866606 |
47 | MARK2 | 1.05661641 |
48 | ITK | 1.01285462 |
49 | IRAK3 | 1.00596166 |
50 | BMPR2 | 1.00443516 |
51 | CDC42BPA | 0.99725552 |
52 | TAOK2 | 0.96077963 |
53 | STK10 | 0.95603870 |
54 | DYRK1B | 0.93385456 |
55 | MARK3 | 0.92019178 |
56 | MAP3K7 | 0.91890708 |
57 | CAMKK2 | 0.82778694 |
58 | FGFR3 | 0.81883399 |
59 | TESK2 | 0.78111148 |
60 | YES1 | 0.77214540 |
61 | PDK1 | 0.73681124 |
62 | STK38 | 0.73014110 |
63 | IRAK1 | 0.68829502 |
64 | TIE1 | 0.68589819 |
65 | IRAK2 | 0.66670870 |
66 | FYN | 0.66479319 |
67 | PTK6 | 0.66077195 |
68 | CDK12 | 0.63920636 |
69 | SIK1 | 0.61849537 |
70 | PRKCQ | 0.60815107 |
71 | MOS | 0.60397501 |
72 | MAPK7 | 0.59918167 |
73 | HIPK2 | 0.58885673 |
74 | PDPK1 | 0.58695384 |
75 | TRIB3 | 0.57716243 |
76 | MAP3K5 | 0.55650072 |
77 | PTK2B | 0.54355297 |
78 | KSR1 | 0.48946836 |
79 | RAF1 | 0.47544359 |
80 | MAPK12 | 0.46950901 |
81 | MAP3K6 | 0.44605648 |
82 | EPHA3 | 0.43829864 |
83 | DYRK3 | 0.43034125 |
84 | PDGFRB | 0.40931943 |
85 | CHUK | 0.40885455 |
86 | PRKG2 | 0.40455281 |
87 | SGK3 | 0.39913575 |
88 | CAMKK1 | 0.39644965 |
89 | RPS6KL1 | 0.39127332 |
90 | RPS6KC1 | 0.39127332 |
91 | BRD4 | 0.38961855 |
92 | RET | 0.38106942 |
93 | DDR2 | 0.37853529 |
94 | MAPKAPK2 | 0.37750930 |
95 | PIK3CG | 0.37307356 |
96 | PIM1 | 0.37234590 |
97 | BCR | 0.32112759 |
98 | LRRK2 | 0.32103937 |
99 | MAP2K6 | 0.32053566 |
100 | STK16 | 0.31708328 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.70809942 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.66163372 |
3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.15939562 |
4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.08319294 |
5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.06082764 |
6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.02589522 |
7 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.97115262 |
8 | Tuberculosis_Homo sapiens_hsa05152 | 1.95659264 |
9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.94929567 |
10 | Allograft rejection_Homo sapiens_hsa05330 | 1.93844581 |
11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.92240580 |
12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.92129777 |
13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.90636713 |
14 | Measles_Homo sapiens_hsa05162 | 1.82464525 |
15 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.80662127 |
16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.74321820 |
17 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.70376872 |
18 | Malaria_Homo sapiens_hsa05144 | 1.69543465 |
19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.69514985 |
20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.66571023 |
21 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.62186595 |
22 | Other glycan degradation_Homo sapiens_hsa00511 | 1.62166922 |
23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.56394779 |
24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.54777466 |
25 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.54481024 |
26 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.49521510 |
27 | Influenza A_Homo sapiens_hsa05164 | 1.49227436 |
28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.48210650 |
29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.44601385 |
30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.40257641 |
31 | Legionellosis_Homo sapiens_hsa05134 | 1.40149412 |
32 | Phagosome_Homo sapiens_hsa04145 | 1.38910411 |
33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.38489516 |
34 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.38395149 |
35 | Viral myocarditis_Homo sapiens_hsa05416 | 1.35703220 |
36 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.35467201 |
37 | Hepatitis B_Homo sapiens_hsa05161 | 1.32125241 |
38 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.30904170 |
39 | Salmonella infection_Homo sapiens_hsa05132 | 1.30016675 |
40 | Shigellosis_Homo sapiens_hsa05131 | 1.28683612 |
41 | Pertussis_Homo sapiens_hsa05133 | 1.27825664 |
42 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.24884224 |
43 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.21821101 |
44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.15994412 |
45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.15357838 |
46 | Hepatitis C_Homo sapiens_hsa05160 | 1.14971101 |
47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.11942871 |
48 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.11588284 |
49 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.08846566 |
50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.07197536 |
51 | Lysosome_Homo sapiens_hsa04142 | 1.01332038 |
52 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.00777391 |
53 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.00234761 |
54 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.97072397 |
55 | Apoptosis_Homo sapiens_hsa04210 | 0.96224040 |
56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.91308003 |
57 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89977781 |
58 | Platelet activation_Homo sapiens_hsa04611 | 0.89927643 |
59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.89904153 |
60 | Endocytosis_Homo sapiens_hsa04144 | 0.88207979 |
61 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.85494432 |
62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.84617557 |
63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.82496614 |
64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80164561 |
65 | Asthma_Homo sapiens_hsa05310 | 0.79495418 |
66 | Amoebiasis_Homo sapiens_hsa05146 | 0.79180535 |
67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74743285 |
68 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71440972 |
69 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.70870162 |
70 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.70496303 |
71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.68899969 |
72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68596935 |
73 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64528539 |
74 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.64424514 |
75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63989479 |
76 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60010671 |
77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58679502 |
78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58194043 |
79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.57075972 |
80 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55347587 |
81 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55130977 |
82 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54372638 |
83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53253076 |
84 | HTLV-I infection_Homo sapiens_hsa05166 | 0.52466084 |
85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51897143 |
86 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51346807 |
87 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51197129 |
88 | Bladder cancer_Homo sapiens_hsa05219 | 0.49726185 |
89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.48912108 |
90 | Insulin resistance_Homo sapiens_hsa04931 | 0.48291359 |
91 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47924101 |
92 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.46858476 |
93 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46544819 |
94 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.44784002 |
95 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.41631679 |
96 | Colorectal cancer_Homo sapiens_hsa05210 | 0.38761493 |
97 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.38748649 |
98 | Prostate cancer_Homo sapiens_hsa05215 | 0.38080557 |
99 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.36849754 |
100 | Focal adhesion_Homo sapiens_hsa04510 | 0.35676902 |